World’s 1st Nasal Vaccine Out On Republic Day: All You Need To Know

iNCOVACC: Bharat Biotech in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose

Bharat Biotech’s nasal Covid vaccine to be priced at Rs 800 for private and Rs 325 for govt hospitals

The Centre on Tuesday approved the cost of Bharat Biotech’s nasal COVID-19 vaccine iNCOVACC, which will be used as a booster dose for those above 18 years, at Rs 800 for private hospitals and Rs 325 for the government ones. The vaccine iNCOVACC® will be rolled out in the fourth week of January. The Union […]

India starts nasal vaccine. Where can you get it? How to use? Who can use? Check details here

Those who have taken Covishield and Covaxin can take the nasal vaccine as a heterologous booster dose.

COVID-19: Bharat Biotech releases Phase 3 trial results of Covaxin, claims vaccine efficacy of 78.8 pc

Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent effective against COVID-19. It also added that Covaxin gives 65.2 per cent protection against the SARS-CoV-2, B.1.617.2 Delta variant. “Efficacy analysis demonstrates Covaxin to be 77.8 per cent effective against […]

Bharat Biotech’s Covaxin shows 77.8 pc efficacy in Phase III trials, say sources

Bharat Biotech’s Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday, according to sources. The Hyderabad-based COVID vaccine manufacturing company had submitted data from the Phase III clinical trials of Covaxin to the Drugs Controller General of India (DCGI) […]

Covaxin effective on UK virus strain of COVID-19: ICMR

An Indian Council of Medical Research (ICMR) study on Covaxin shows a comparable neutralization activity of the vaccinated individuals against UK-variant strain. The ICMR’s National Institute of Virology scientist performed the plaque reduction neutralization test using sera collected from the 26 recipients of Bharat Biotech’s coronavirus vaccine (COVAXIN) against UK-variant strain. “A comparable neutralization activity […]

Bharat Biotech to pay compensation if Covaxin causes side effects in recipients

Bharat Biotech, which has received a government purchase order for supply of 55 lakh doses of Covaxin, a COVID-19 vaccine, said the company will pay compensation to recipients in case of any serious adverse effects experienced after receiving the antidote. In the consent form to be signed by the vaccine recipients, Bharat Biotech said, “In […]

Covaxin row: Bharat Biotech clarifies allegations over volunteer who died after shot

After a participant who allegedly died days after volunteering for Covaxin trial in Bhopal, Bharat Biotech on Saturday clarified that the volunteer, at the time of enrolment, had fulfilled all the inclusion and exclusion criteria to be accepted as a participant in the Phase III trial and was reported to be healthy in all the […]

Covaxin is 200% safe, says Bharat Biotech Chairman

Covaxin, the indigenous vaccine developed by Bharat Biotech against COVID-19 in collaboration with ICMR, is 200 percent safe, company’s Chairman and Managing Director Dr Krishna Ella has said and noted that it has shown less than 10 percent adverse reaction in trials so far. “Covaxin has shown less than 10 percent adverse reactions, while others […]